Circadian Rhythm Disruption Identified as a Key Factor in Treatment-Resistant Depression

University of Sydney researchers have identified a depression subtype linked to severe disruptions in sleep and daily biological rhythms, termed 'circadian depression.' It affects nearly a quarter of individuals with severe depression in a large Australian study. This finding suggests current antidepressants may be ineffective for patients whose condition stems from internal clock dysregulation.

University of Sydney researchers have identified a distinct subtype of severe depression tied to profound disruptions in circadian rhythms, now termed 'circadian depression.' This finding emerged from a large-scale Australian study revealing that nearly one in four individuals with severe depression exhibit this specific pattern of biological rhythm disturbance. The discovery highlights a potential reason why standard antidepressants may fail for certain patients—those whose condition is rooted in internal clock dysregulation rather than purely chemical imbalances. While the exact mechanisms linking circadian disruption to treatment resistance remain unclear, the study underscores the need to reevaluate diagnostic and therapeutic approaches for depression. The research team at the University of Sydney is now exploring how targeted interventions, such as light therapy or chronotherapeutics, might improve outcomes for this subgroup.

Prior assumptions about depression have largely centered on neurotransmitter imbalances, leading to widespread use of SSRIs and other pharmacological treatments that may not address underlying circadian dysfunction. This new evidence suggests that current treatment paradigms, which often treat depression as a monolithic condition, may be inadequate for a significant subset of patients. The University of Sydney’s work builds on growing recognition in neuroscience that the body's internal clock influences mood regulation, sleep architecture, and cogn